Warby Parker Newsroom

Warby Parker Analyst Ratings

BenzingaDec 16 19:18

Analysts Offer Insights on Healthcare Companies: Arcutis Biotherapeutics (ARQT) and Warby Parker (WRBY)

TipRanksDec 16 14:53

JMP Securities Maintains Warby Parker(WRBY.US) With Buy Rating, Raises Target Price to $28

Futu NewsDec 16 14:31

Baird Maintains Warby Parker(WRBY.US) With Buy Rating, Raises Target Price to $30

Futu NewsDec 14 00:31

Warby Parker Is Maintained at Hold by Stifel

Dow JonesDec 12 00:13

Goldman Sachs Maintains Warby Parker(WRBY.US) With Buy Rating, Raises Target Price to $26

Futu NewsDec 11 00:31

Warby Parker Is Maintained at Buy by Goldman Sachs

Dow JonesDec 10 22:54

Warby Parker Price Target Raised to $26.00/Share From $20.00 by Goldman Sachs

Dow JonesDec 10 22:54

Telsey Advisory Maintains Warby Parker(WRBY.US) With Buy Rating, Maintains Target Price $26

Futu NewsNov 21 22:32

Warby Parker Analyst Ratings

BenzingaNov 20 01:07

Telsey Advisory Maintains Warby Parker(WRBY.US) With Buy Rating, Raises Target Price to $26

Futu NewsNov 19 22:32

Telsey Advisory Maintains Warby Parker(WRBY.US) With Buy Rating, Maintains Target Price $22

Futu NewsNov 13 22:31

Telsey Advisory Maintains Warby Parker(WRBY.US) With Buy Rating, Maintains Target Price $22

Futu NewsNov 12 22:31

Telsey Advisory Maintains Warby Parker(WRBY.US) With Buy Rating, Maintains Target Price $22

Futu NewsNov 11 22:31

A Quick Look at Today's Ratings for Warby Parker(WRBY.US), With a Forecast Between $20 to $23

Futu NewsNov 9 21:08

Warby Parker Is Maintained at Overweight by Piper Sandler

Dow JonesNov 8 22:42

Morgan Stanley Remains a Hold on Warby Parker (WRBY)

TipRanksNov 8 22:35

Warby Parker Analyst Ratings

BenzingaNov 8 22:32

A Quick Look at Today's Ratings for Warby Parker(WRBY.US), With a Forecast Between $19 to $23

Futu NewsNov 8 21:13

Morgan Stanley Adjusts Warby Parker's Price Target to $17 From $14, Keeps Equalweight Rating

MT NewswiresNov 8 20:34